BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 17598045)

  • 1. Genital graft-versus-host disease in a male following allogeneic stem cell transplantation.
    Nylander E; Wahlin YB; Lundskog B; Wahlin A
    Acta Derm Venereol; 2007; 87(4):367-8. PubMed ID: 17598045
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronic graft versus host disease.
    Higman MA; Vogelsang GB
    Br J Haematol; 2004 May; 125(4):435-54. PubMed ID: 15142114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Follicular graft-versus-host disease: a rare manifestation of chronic cutaneous graft-versus-host disease.
    Martí N; Martin JM; Monteagudo C; López V; Jordá E
    Am J Dermatopathol; 2008 Dec; 30(6):620-1. PubMed ID: 19033942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute lung injury after allogeneic stem cell transplantation: is the lung a target of acute graft-versus-host disease?
    Cooke KR; Yanik G
    Bone Marrow Transplant; 2004 Nov; 34(9):753-65. PubMed ID: 15300233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central nervous system graft-versus-host disease presenting with granulomatous encephalitis.
    Kew AK; Macaulay R; Burrell S; Rubin S; Dow G; Couban S
    Bone Marrow Transplant; 2007 Jul; 40(2):183-4. PubMed ID: 17502894
    [No Abstract]   [Full Text] [Related]  

  • 6. Facial rash mimicking cutaneous acute graft-versus-host disease after allogeneic stem cell transplantation for osteomyelofibrosis - was Demodex the culprit?
    Lotze C; Krüger WH; Kiefer T; Swensson O; Herbst EW; Schüler F; Busemann C; Dölken G
    Bone Marrow Transplant; 2006 Apr; 37(7):711-2. PubMed ID: 16474408
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical impact of human Jurkat T-cell-line-derived antithymocyte globulin in multiple myeloma patients undergoing allogeneic stem cell transplantation.
    Ayuk F; Perez-Simon JA; Shimoni A; Sureda A; Zabelina T; Schwerdtfeger R; Martino R; Sayer HG; Alegre A; Lahuerta JJ; Atanackovic D; Wolschke C; Nagler A; Zander AR; San Miguel JF; Kröger N
    Haematologica; 2008 Sep; 93(9):1343-50. PubMed ID: 18641030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hookworm infection of sigmoid colon masquerading as graft-versus-host disease in an allogeneic stem cell transplant recipient after donor lymphocyte infusion for refractory acute promyelocytic leukemia.
    Ozdemir E; Molldrem JJ
    Bone Marrow Transplant; 2006 Apr; 37(8):785-6. PubMed ID: 16501592
    [No Abstract]   [Full Text] [Related]  

  • 9. Two cases of cutaneous chronic graft versus host disease in treatment with psoralen plus ultraviolet-A-bath photochemotherapy.
    Hoffner MV; Carrizosa Esquivel A; Pulpillo Ruiz A; Herrera Saval A; Conejo-Mir J; Camacho FM
    J Drugs Dermatol; 2009 Nov; 8(11):1027-9. PubMed ID: 19894371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of autoantibody expression in allogeneic stem-cell recipients.
    Moon JH; Lee SJ; Kim JG; Chae YS; Kim SN; Kang BW; Suh JS; Lee KS; Sohn SK
    Transplantation; 2009 Jul; 88(2):242-50. PubMed ID: 19623021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using capsule endoscopy to diagnose graft-versus-host disease: seeing is believing?
    Eisen GM
    Gastrointest Endosc; 2007 Mar; 65(3):410-1. PubMed ID: 17321240
    [No Abstract]   [Full Text] [Related]  

  • 12. B-cell involvement in chronic graft-versus-host disease.
    Kapur R; Ebeling S; Hagenbeek A
    Haematologica; 2008 Nov; 93(11):1702-11. PubMed ID: 18728020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Graft-versus-host disease of the CNS after allogeneic bone marrow transplantation.
    Saad AG; Alyea EP; Wen PY; Degirolami U; Kesari S
    J Clin Oncol; 2009 Oct; 27(30):e147-9. PubMed ID: 19667266
    [No Abstract]   [Full Text] [Related]  

  • 14. Allogeneic stem cell transplantation in first complete remission enhances graft-versus-leukemia effect in adults with acute lymphoblastic leukemia: antileukemic activity of chronic graft-versus-host disease.
    Lee S; Cho BS; Kim SY; Choi SM; Lee DG; Eom KS; Kim YJ; Kim HJ; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Shin WS; Kim CC
    Biol Blood Marrow Transplant; 2007 Sep; 13(9):1083-94. PubMed ID: 17697971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allogeneic stem cell transplantation after reduced-intensity conditioning for acute myeloid leukaemia: impact of chronic graft-versus-host disease.
    Valcárcel D; Martino R; Piñana JL; Sierra J
    Curr Opin Oncol; 2009 Jun; 21 Suppl 1():S35-7. PubMed ID: 19561412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of late graft-versus-host disease in a patient post-allogeneic stem cell transplantation by progesterone in conjunction with donor lymphocyte infusion.
    Gesundheit B; Shapira MY; Maly A; Samuel S; Budowski E; Or R
    Leuk Res; 2008 Mar; 32(3):501-3. PubMed ID: 17727947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical tacrolimus in severe chronic graft-versus-host disease.
    Heinemann C; Kaatz M; Schreiber G; Elsner P; Norgauer J
    Acta Derm Venereol; 2005; 85(4):370-1. PubMed ID: 16191870
    [No Abstract]   [Full Text] [Related]  

  • 18. Graft-versus-disease effect following allogeneic transplantation for acute leukaemia.
    Rowe JM
    Best Pract Res Clin Haematol; 2008 Sep; 21(3):485-502. PubMed ID: 18790451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of oral chronic graft-versus-host disease.
    Stoopler ET
    J Can Dent Assoc; 2013; 79():d37. PubMed ID: 23763728
    [No Abstract]   [Full Text] [Related]  

  • 20. A comparison between low intensity and reduced intensity conditioning in allogeneic hematopoietic stem cell transplantation for solid tumors.
    Conrad R; Remberger M; Cederlund K; Ringdén O; Barkholt L
    Haematologica; 2008 Feb; 93(2):265-72. PubMed ID: 18245651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.